35431946|t|Acute Administration of Metformin Protects Against Neuronal Apoptosis Induced by Cerebral Ischemia-Reperfusion Injury via Regulation of the AMPK/CREB/BDNF Pathway.
35431946|a|Metformin is a first-line anti-diabetic agent with a powerful hypoglycemic effect. Several studies have reported that metformin can improve the prognosis of stroke patients and that this effect is independent of its hypoglycemic effect; however, the specific mechanism remains unclear. In this research, we explored the effect and specific mechanism of metformin in cerebral ischemia-reperfusion (I/R) injury by constructing a transient middle cerebral artery occlusion model in vivo and a glucose and oxygen deprivation/reoxygenation (OGD/R) model in vitro. The results of the in vivo experiments showed that acute treatment with low-dose metformin (10 mg/kg) ameliorated cerebral edema, reduced the cerebral infarction volume, improved the neurological deficit score, and ameliorated neuronal apoptosis in the ischemic penumbra. Moreover, metformin up-regulated the brain-derived neurotrophic factor (BDNF) expression and increased phosphorylation levels of AMP-activated protein kinase (AMPK) and cAMP-response element binding protein (CREB) in the ischemia penumbra. Nevertheless, the above-mentioned effects of metformin were reversed by Compound C. The results of the in vitro experiments showed that low metformin concentrations (20 muM) could reduce apoptosis of human umbilical vein endothelial cells (HUVECs) under OGD/R conditions and promote cell proliferation. Moreover, metformin could further promote BDNF expression and release in HUVECs under OGD/R conditions via the AMPK/CREB pathway. The Transwell chamber assay showed that HUVECs treated with metformin could reduce apoptosis of SH-SY5Y cells under OGD/R conditions and this effect could be partially reversed by transfection of BDNF siRNA in HUVECs. In summary, our results suggest that metformin upregulates the level of BDNF in the cerebral ischemic penumbra via the AMPK/CREB pathway, thereby playing a protective effect in cerebral I/R injury.
35431946	24	33	Metformin	Chemical	MESH:D008687
35431946	81	110	Cerebral Ischemia-Reperfusion	Disease	MESH:D002545
35431946	111	117	Injury	Disease	MESH:D014947
35431946	140	144	AMPK	Gene	5564
35431946	145	149	CREB	Gene	1385
35431946	150	154	BDNF	Gene	627
35431946	164	173	Metformin	Chemical	MESH:D008687
35431946	195	203	diabetic	Disease	MESH:D003920
35431946	282	291	metformin	Chemical	MESH:D008687
35431946	321	327	stroke	Disease	MESH:D020521
35431946	328	336	patients	Species	9606
35431946	517	526	metformin	Chemical	MESH:D008687
35431946	530	559	cerebral ischemia-reperfusion	Disease	MESH:D002545
35431946	561	572	I/R) injury	Disease	MESH:D015427
35431946	601	633	middle cerebral artery occlusion	Disease	MESH:D020244
35431946	654	661	glucose	Chemical	MESH:D005947
35431946	666	672	oxygen	Chemical	MESH:D010100
35431946	700	703	OGD	Disease	MESH:C536050
35431946	804	813	metformin	Chemical	MESH:D008687
35431946	837	851	cerebral edema	Disease	MESH:D001929
35431946	865	884	cerebral infarction	Disease	MESH:D002544
35431946	906	926	neurological deficit	Disease	MESH:D009461
35431946	976	984	ischemic	Disease	MESH:D002545
35431946	1005	1014	metformin	Chemical	MESH:D008687
35431946	1032	1065	brain-derived neurotrophic factor	Gene	627
35431946	1067	1071	BDNF	Gene	627
35431946	1124	1152	AMP-activated protein kinase	Gene	5564
35431946	1154	1158	AMPK	Gene	5564
35431946	1164	1201	cAMP-response element binding protein	Gene	1385
35431946	1203	1207	CREB	Gene	1385
35431946	1216	1224	ischemia	Disease	MESH:D007511
35431946	1280	1289	metformin	Chemical	MESH:D008687
35431946	1307	1318	Compound C.	Chemical	-
35431946	1375	1384	metformin	Chemical	MESH:D008687
35431946	1435	1440	human	Species	9606
35431946	1489	1492	OGD	Disease	MESH:C536050
35431946	1493	1494	R	Disease	MESH:C580424
35431946	1548	1557	metformin	Chemical	MESH:D008687
35431946	1580	1584	BDNF	Gene	627
35431946	1624	1627	OGD	Disease	MESH:C536050
35431946	1649	1653	AMPK	Gene	5564
35431946	1654	1658	CREB	Gene	1385
35431946	1728	1737	metformin	Chemical	MESH:D008687
35431946	1764	1771	SH-SY5Y	CellLine	CVCL:0019
35431946	1784	1787	OGD	Disease	MESH:C536050
35431946	1864	1868	BDNF	Gene	627
35431946	1923	1932	metformin	Chemical	MESH:D008687
35431946	1958	1962	BDNF	Gene	627
35431946	1970	1996	cerebral ischemic penumbra	Disease	MESH:D002547
35431946	2005	2009	AMPK	Gene	5564
35431946	2010	2014	CREB	Gene	1385
35431946	2063	2082	cerebral I/R injury	Disease	MESH:D015427
35431946	Positive_Correlation	MESH:D008687	627
35431946	Association	MESH:D002547	627
35431946	Negative_Correlation	MESH:D008687	MESH:D002545
35431946	Negative_Correlation	MESH:D008687	MESH:C536050
35431946	Negative_Correlation	MESH:D008687	MESH:D020521
35431946	Negative_Correlation	MESH:D008687	MESH:D001929
35431946	Positive_Correlation	MESH:D008687	MESH:D009461
35431946	Negative_Correlation	MESH:D008687	MESH:C580424
35431946	Association	MESH:D015427	5564
35431946	Negative_Correlation	MESH:D008687	MESH:D014947
35431946	Association	1385	627
35431946	Negative_Correlation	MESH:D008687	MESH:D002544
35431946	Association	MESH:D015427	1385
35431946	Association	5564	627
35431946	Negative_Correlation	MESH:D008687	MESH:D015427
35431946	Negative_Correlation	MESH:D008687	MESH:D003920
35431946	Positive_Correlation	MESH:D008687	5564
35431946	Association	MESH:C536050	627
35431946	Association	1385	5564
35431946	Association	MESH:D015427	627
35431946	Positive_Correlation	MESH:D008687	1385
35431946	Positive_Correlation	MESH:D008687	MESH:D002547

